Overview

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Status:
Recruiting
Trial end date:
2025-11-25
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes (T2D). The study will lasts around 31 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company